USPTO serial 79214190
IMMUNOSIGN
Reviewed by CopyMark Law Group
Reg. 5572566Status 708Registered
- Filing date
- Status date
- Registration date
- Oct 2, 2018
- Examiner
- CROWLEY, SEAN MICHAEL
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with IMMUNOSIGN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Marseille, FR
F-13288 Marseille Cédex 09, FR
FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas R. Wolf
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical products being chemical or biological preparations for medical and pharmaceutical use for use in vitro testing, for use in the clinical diagnostic, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; biological reagents for medical use for providing information on diagnostic or identification of biological systems; biological reagents for pharmaceutical use for providing information on diagnostics or identification of biological systems ] | SECTION 71 - CANCELLED | — |
| 009 | [ Software for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition, in the field of biology; application software in the nature of a mobile application for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition in the field of biology ] | SECTION 71 - CANCELLED | — |
| 010 | [ medical apparatus and instruments for providing information on diagnostics or identification of biological systems, namely, gene expression analysis and markers detection devices, medical testing devices and diagnostic apparatus for detecting, analyzing or assessing a cancer, tumor or equivalent medical condition; medical instruments for cell detection in the context of a cancer, tumor or equivalent medical condition ] | SECTION 71 - CANCELLED | — |
| 044 | Medical analysis services; medical assistance; health services; medical therapeutic services; medical diagnostics, diagnostics in the field of medicine; genetic analysis services for medical purposes, namely, analysis of a medical disorder, tumor, cancer or equivalent medical condition | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Veracyte
- Other trademarks owned by HalioDx
- Other trademarks owned by HalioDx
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named IMMUNOSIGN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 26, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 10, 2026 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 10, 2026 | INPC | INVALIDATION PROCESSED | — |
| Aug 26, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 26, 2024 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Dec 26, 2024 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Dec 26, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 22, 2024 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Oct 2, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 12, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 1, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 15, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 14, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 2, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 2, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 17, 2018 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Jul 17, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 17, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 14, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 27, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 27, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 27, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 8, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 8, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 8, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 8, 2018 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jun 8, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 7, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 6, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 6, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 28, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 23, 2018 | ALIE | ASSIGNED TO LIE | — |
| Feb 15, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 15, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 25, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 25, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 24, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 23, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 16, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 16, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 10, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |